Brief: Neovacs H1 Net Loss Shrinks To 3.2 Million Euros
Oct 28 (Reuters) - NEOVACS SA ALNEV.PA :
* NEOVACS PUBLISHES SOLID HALF-YEAR FINANCIAL STATEMENTS
CONFIRMING EXECUTION OF BUSINESS PLAN
* FINANCIAL STRUCTURE STRENGTHENED WITH €35M OF CASH AT THE
END OF
JUNE
* AT JUNE 30, 2021, ONLY €0.2 MILLION IN FINANCIAL DEBT
* HALF-YEAR OPERATING INCOME AT -3.4 M € COMPARED TO -1.8 M
€ IN
THE FIRST HALF OF 2020
* HALF-YEAR NET RESULT (LOSS) HAS IMPROVED SIGNIFICANTLY, AT
-3.2
M € COMPARED TO -6.4 M € YEAR AGO
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants